Cardiovascular involvement in COVID-19

Descripción del Articulo

Cardiovascular compromise among COVID-19 patients, especially in the subpopulation with cardiovascular risk factors, is associated with severity of disease and a higher mortality in some case-series.The most clearly described pathophysiological mechanisms are direct myocardial injury and the process...

Descripción completa

Detalles Bibliográficos
Autores: Germán, Valenzuela-Rodríguez, Amado-Tineo, Percy
Formato: artículo
Fecha de Publicación:2020
Institución:Sociedad Peruana de Medicina Interna
Repositorio:Revista SPMI - Revista de la Sociedad Peruana de Medicina Interna
Lenguaje:español
OAI Identifier:oai:ojs.medicinainterna.net.pe:article/522
Enlace del recurso:http://revistamedicinainterna.net/index.php/spmi/article/view/522
Nivel de acceso:acceso abierto
Materia:SARS-CoV-2
COVID-19
cardiovascular
myocardial injury
myocarditis
cardiomyopathies
heart failure
acute coronary syndromes
arrhythmias
thromboembolism
SARS-Cov-2
injuria miocárdica
miocarditis
miocardiopatías
insuficiencia cardíaca
síndromes coronarios agudos
arritmias
tromboembolismo
id 1609-7173_5f7e1ff1d5b313a8069d2a3ff6d53e19
oai_identifier_str oai:ojs.medicinainterna.net.pe:article/522
network_acronym_str 1609-7173
repository_id_str
network_name_str Revista SPMI - Revista de la Sociedad Peruana de Medicina Interna
spelling Cardiovascular involvement in COVID-19Compromiso cardiovascular en COVID-19Germán, Valenzuela-RodríguezAmado-Tineo, PercySARS-CoV-2COVID-19cardiovascularmyocardial injurymyocarditiscardiomyopathiesheart failureacute coronary syndromesarrhythmiasthromboembolismSARS-Cov-2COVID-19cardiovascularinjuria miocárdicamiocarditismiocardiopatíasinsuficiencia cardíacasíndromes coronarios agudosarritmiastromboembolismoCardiovascular compromise among COVID-19 patients, especially in the subpopulation with cardiovascular risk factors, is associated with severity of disease and a higher mortality in some case-series.The most clearly described pathophysiological mechanisms are direct myocardial injury and the process associated with systemic inflammation. Cardiovascular manifestations are diverse and include myocardial injury, myocarditis, cardiomyopathies, heart failure, acute coronary syndromes, arrhythmias, thromboembolic events. Moreover, we must consider the adverse effects of medications used to treat the viral infection.El compromiso cardiovascular de los pacientes con COVID-19, especialmente en la subpoblación con factores de riesgo cardiovasculares, se asocia a la severidad de la enfermedad e inclusive a una mayor mortalidad en algunas series de casos. Los mecanismos fisiopatológicos descritos con mayor claridad son la injuria miocárdica directa y el proceso asociado a la inflamación sistémica. Las manifestaciones cardiovasculares son diversas e incluyen injuria miocárdica, miocarditis, miocardiopatías, insuficiencia cardíaca, síndromes coronarios agudos, arritmias, eventos tromboembólicos. Adicionalmente, debemos considerar los efectos adversos de los medicamentos utilizados para tratar la infección viral.Sociedad Peruana de Medicina Interna2020-06-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmlhttp://revistamedicinainterna.net/index.php/spmi/article/view/52210.36393/spmi.v33i2.522Revista de la Sociedad Peruana de Medicina Interna; Vol. 33 Núm. 2 (2020); 61-67Revista de la Sociedad Peruana de Medicina Interna; Vol 33 No 2 (2020); 61-671609-71731681-972110.36393/spmi.v33i2reponame:Revista SPMI - Revista de la Sociedad Peruana de Medicina Internainstname:Sociedad Peruana de Medicina Internainstacron:SPMIspahttp://revistamedicinainterna.net/index.php/spmi/article/view/522/587http://revistamedicinainterna.net/index.php/spmi/article/view/522/609info:eu-repo/semantics/openAccess2021-05-29T16:56:13Zmail@mail.com -
dc.title.none.fl_str_mv Cardiovascular involvement in COVID-19
Compromiso cardiovascular en COVID-19
title Cardiovascular involvement in COVID-19
spellingShingle Cardiovascular involvement in COVID-19
Germán, Valenzuela-Rodríguez
SARS-CoV-2
COVID-19
cardiovascular
myocardial injury
myocarditis
cardiomyopathies
heart failure
acute coronary syndromes
arrhythmias
thromboembolism
SARS-Cov-2
COVID-19
cardiovascular
injuria miocárdica
miocarditis
miocardiopatías
insuficiencia cardíaca
síndromes coronarios agudos
arritmias
tromboembolismo
title_short Cardiovascular involvement in COVID-19
title_full Cardiovascular involvement in COVID-19
title_fullStr Cardiovascular involvement in COVID-19
title_full_unstemmed Cardiovascular involvement in COVID-19
title_sort Cardiovascular involvement in COVID-19
dc.creator.none.fl_str_mv Germán, Valenzuela-Rodríguez
Amado-Tineo, Percy
author Germán, Valenzuela-Rodríguez
author_facet Germán, Valenzuela-Rodríguez
Amado-Tineo, Percy
author_role author
author2 Amado-Tineo, Percy
author2_role author
dc.subject.none.fl_str_mv SARS-CoV-2
COVID-19
cardiovascular
myocardial injury
myocarditis
cardiomyopathies
heart failure
acute coronary syndromes
arrhythmias
thromboembolism
SARS-Cov-2
COVID-19
cardiovascular
injuria miocárdica
miocarditis
miocardiopatías
insuficiencia cardíaca
síndromes coronarios agudos
arritmias
tromboembolismo
topic SARS-CoV-2
COVID-19
cardiovascular
myocardial injury
myocarditis
cardiomyopathies
heart failure
acute coronary syndromes
arrhythmias
thromboembolism
SARS-Cov-2
COVID-19
cardiovascular
injuria miocárdica
miocarditis
miocardiopatías
insuficiencia cardíaca
síndromes coronarios agudos
arritmias
tromboembolismo
dc.description.none.fl_txt_mv Cardiovascular compromise among COVID-19 patients, especially in the subpopulation with cardiovascular risk factors, is associated with severity of disease and a higher mortality in some case-series.The most clearly described pathophysiological mechanisms are direct myocardial injury and the process associated with systemic inflammation. Cardiovascular manifestations are diverse and include myocardial injury, myocarditis, cardiomyopathies, heart failure, acute coronary syndromes, arrhythmias, thromboembolic events. Moreover, we must consider the adverse effects of medications used to treat the viral infection.
El compromiso cardiovascular de los pacientes con COVID-19, especialmente en la subpoblación con factores de riesgo cardiovasculares, se asocia a la severidad de la enfermedad e inclusive a una mayor mortalidad en algunas series de casos. Los mecanismos fisiopatológicos descritos con mayor claridad son la injuria miocárdica directa y el proceso asociado a la inflamación sistémica. Las manifestaciones cardiovasculares son diversas e incluyen injuria miocárdica, miocarditis, miocardiopatías, insuficiencia cardíaca, síndromes coronarios agudos, arritmias, eventos tromboembólicos. Adicionalmente, debemos considerar los efectos adversos de los medicamentos utilizados para tratar la infección viral.
description Cardiovascular compromise among COVID-19 patients, especially in the subpopulation with cardiovascular risk factors, is associated with severity of disease and a higher mortality in some case-series.The most clearly described pathophysiological mechanisms are direct myocardial injury and the process associated with systemic inflammation. Cardiovascular manifestations are diverse and include myocardial injury, myocarditis, cardiomyopathies, heart failure, acute coronary syndromes, arrhythmias, thromboembolic events. Moreover, we must consider the adverse effects of medications used to treat the viral infection.
publishDate 2020
dc.date.none.fl_str_mv 2020-06-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://revistamedicinainterna.net/index.php/spmi/article/view/522
10.36393/spmi.v33i2.522
url http://revistamedicinainterna.net/index.php/spmi/article/view/522
identifier_str_mv 10.36393/spmi.v33i2.522
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv http://revistamedicinainterna.net/index.php/spmi/article/view/522/587
http://revistamedicinainterna.net/index.php/spmi/article/view/522/609
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv Sociedad Peruana de Medicina Interna
publisher.none.fl_str_mv Sociedad Peruana de Medicina Interna
dc.source.none.fl_str_mv Revista de la Sociedad Peruana de Medicina Interna; Vol. 33 Núm. 2 (2020); 61-67
Revista de la Sociedad Peruana de Medicina Interna; Vol 33 No 2 (2020); 61-67
1609-7173
1681-9721
10.36393/spmi.v33i2
reponame:Revista SPMI - Revista de la Sociedad Peruana de Medicina Interna
instname:Sociedad Peruana de Medicina Interna
instacron:SPMI
reponame_str Revista SPMI - Revista de la Sociedad Peruana de Medicina Interna
collection Revista SPMI - Revista de la Sociedad Peruana de Medicina Interna
instname_str Sociedad Peruana de Medicina Interna
instacron_str SPMI
institution SPMI
repository.name.fl_str_mv -
repository.mail.fl_str_mv mail@mail.com
_version_ 1701112607055806464
score 13.958958
Cardiovascular involvement in COVID-19
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).

Ejemplares Similares